JP2015509079A5 - - Google Patents

Download PDF

Info

Publication number
JP2015509079A5
JP2015509079A5 JP2014546562A JP2014546562A JP2015509079A5 JP 2015509079 A5 JP2015509079 A5 JP 2015509079A5 JP 2014546562 A JP2014546562 A JP 2014546562A JP 2014546562 A JP2014546562 A JP 2014546562A JP 2015509079 A5 JP2015509079 A5 JP 2015509079A5
Authority
JP
Japan
Prior art keywords
nanoparticle
hafnium oxide
nanoparticles
metal
crystallite
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014546562A
Other languages
English (en)
Japanese (ja)
Other versions
JP6042450B2 (ja
JP2015509079A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/075731 external-priority patent/WO2013087920A1/en
Publication of JP2015509079A publication Critical patent/JP2015509079A/ja
Publication of JP2015509079A5 publication Critical patent/JP2015509079A5/ja
Application granted granted Critical
Publication of JP6042450B2 publication Critical patent/JP6042450B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014546562A 2011-12-16 2012-12-17 金属材料および酸化ハフニウム材料を含むナノ粒子、その製造および使用 Active JP6042450B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161576437P 2011-12-16 2011-12-16
EP11193968.2 2011-12-16
EP11193968 2011-12-16
US61/576,437 2011-12-16
PCT/EP2012/075731 WO2013087920A1 (en) 2011-12-16 2012-12-17 Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof

Publications (3)

Publication Number Publication Date
JP2015509079A JP2015509079A (ja) 2015-03-26
JP2015509079A5 true JP2015509079A5 (https=) 2015-12-17
JP6042450B2 JP6042450B2 (ja) 2016-12-14

Family

ID=48611880

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014546562A Active JP6042450B2 (ja) 2011-12-16 2012-12-17 金属材料および酸化ハフニウム材料を含むナノ粒子、その製造および使用

Country Status (16)

Country Link
US (1) US10945965B2 (https=)
EP (1) EP2790682B1 (https=)
JP (1) JP6042450B2 (https=)
KR (1) KR102025743B1 (https=)
CN (1) CN104093401B (https=)
AU (1) AU2012351537B2 (https=)
BR (1) BR112014014412A2 (https=)
CA (1) CA2857260C (https=)
EA (1) EA029635B1 (https=)
HK (1) HK1203353A1 (https=)
IL (1) IL233035B (https=)
MA (1) MA35851B1 (https=)
MX (1) MX362089B (https=)
PL (1) PL2790682T3 (https=)
SG (1) SG11201403096VA (https=)
WO (1) WO2013087920A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013009701A2 (en) 2011-07-08 2013-01-17 The University Of North Carolina At Chapel Hill Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
EA029635B1 (ru) 2011-12-16 2018-04-30 Нанобиотикс Применение наночастицы, включающей металлический материал, покрытый материалом оксида гафния, в онкологии и композиция, ее содержащая
AR094577A1 (es) * 2013-01-25 2015-08-12 Nanobiotix Composiciones para el tratamiento de cáncer, preparación y usos de las mismas
EA201690050A1 (ru) * 2013-06-20 2016-05-31 Нанобиотикс Композиции и способы для применения в медицинской диагностике
US10806694B2 (en) * 2014-10-14 2020-10-20 The University Of Chicago Nanoparticles for photodynamic therapy, X-ray induced photodynamic therapy, radiotherapy, radiodynamic therapy, chemotherapy, immunotherapy, and any combination thereof
CN110731961A (zh) 2014-10-14 2020-01-31 芝加哥大学 金属有机框架、药物制剂及其在制备药物中的用途
UA124572C2 (uk) 2015-05-28 2021-10-13 Нанобіотікс Наночастинки для застосування як терапевтичної вакцини
US11389536B2 (en) * 2015-07-17 2022-07-19 BioCurity Pharmaceuticals Inc. Treatment of cancer with a combination of radiation, cerium oxide nanoparticles, and a chemotherapeutic agent
US9607952B1 (en) * 2015-10-30 2017-03-28 International Business Machines Corporation High-z oxide nanoparticles embedded in semiconductor package
EP3439666A4 (en) 2016-05-20 2019-12-11 The University of Chicago NANOPARTICLES FOR CHEMOTHERAPY, TARGETED THERAPY, PHOTODYNAMIC THERAPY, IMMUNOTHERAPY AND ALL COMBINATIONS THEREOF
AU2017384425B2 (en) * 2016-12-21 2023-08-31 Nanobiotix Nanoparticles for use for treating a neuronal disorder
EP3638367A4 (en) 2017-08-02 2021-07-21 The University of Chicago NANOMETRIC ORGANOMETALLIC AND NANOPLAQUE ORGANOMETALLIC LAYERS FOR X-RAY INDUCED PHOTODYNAMIC THERAPY, RADIOTHERAPY, RADIODYNAMIC THERAPY, CHEMOTHERAPY, IMMUNOTHERAPY, AND ANY COMBINATION OF THESE
JP7116563B2 (ja) * 2018-03-16 2022-08-10 株式会社日本触媒 複合粒子
CN109010828B (zh) * 2018-10-12 2020-10-20 中国科学院高能物理研究所 一种二硫化钼/二氧化铪的复合纳米材料、其制备方法及用途
KR20230038659A (ko) * 2020-05-26 2023-03-21 나노비오띡스 나노 입자, 전리 방사선 및 그의 혁신적인 치료용 조합
CN112675305B (zh) * 2021-01-22 2023-05-23 中国科学院深圳先进技术研究院 用于肿瘤治疗的双亲性分子自组装纳米药物及制备方法和用途
JP2024511277A (ja) 2021-02-19 2024-03-13 メビオン・メディカル・システムズ・インコーポレーテッド 粒子線治療システムのためのガントリー
AR131316A1 (es) 2022-12-12 2025-03-05 Nanobiotix S A Novedosas nanopartículas de óxido de metal y composiciones de las mismas para uso como radiopotenciadores o para visualizar tejido biológico

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4280918A (en) 1980-03-10 1981-07-28 International Business Machines Corporation Magnetic particle dispersions
US4672040A (en) 1983-05-12 1987-06-09 Advanced Magnetics, Inc. Magnetic particles for use in separations
US4770183A (en) 1986-07-03 1988-09-13 Advanced Magnetics Incorporated Biologically degradable superparamagnetic particles for use as nuclear magnetic resonance imaging agents
US5225212A (en) 1989-10-20 1993-07-06 Liposome Technology, Inc. Microreservoir liposome composition and method
US6099457A (en) * 1990-08-13 2000-08-08 Endotech, Inc. Endocurietherapy
US5370901A (en) 1991-02-15 1994-12-06 Bracco International B.V. Compositions for increasing the image contrast in diagnostic investigations of the digestive tract of patients
JPH05209072A (ja) * 1992-01-29 1993-08-20 Japan Synthetic Rubber Co Ltd 基材の表面処理方法
WO1993026019A1 (en) 1992-06-08 1993-12-23 Molecular Bioquest, Inc. Preparation of controlled size inorganic particles for use in separations, as magnetic molecular switches, and as inorganic liposomes for medical applications
EP0654973A4 (en) 1992-07-21 1995-08-09 Gen Hospital Corp ARRANGEMENT FOR DELIVERING MEDICINES TO THE LYMPHIC TISSUE.
US5395619A (en) 1993-03-03 1995-03-07 Liposome Technology, Inc. Lipid-polymer conjugates and liposomes
EP0971692B1 (de) 1997-03-07 2003-03-05 Max-Delbrück-Centrum Für Molekulare Medizin Spezifische magnetosomen, verfahren zu ihrer herstellung und ihre verwendung
DE19716732C2 (de) 1997-03-07 1999-03-25 Max Delbrueck Centrum Spezifische Magnetosomen, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19726282A1 (de) 1997-06-20 1998-12-24 Inst Neue Mat Gemein Gmbh Nanoskalige Teilchen mit einem von mindestens zwei Schalen umgebenen eisenoxid-haltigen Kern
US6200598B1 (en) 1998-06-18 2001-03-13 Duke University Temperature-sensitive liposomal formulation
US6726925B1 (en) 1998-06-18 2004-04-27 Duke University Temperature-sensitive liposomal formulation
US6645464B1 (en) 1998-07-30 2003-11-11 James F. Hainfeld Loading metal particles into cell membrane vesicles and metal particular use for imaging and therapy
WO2001037721A2 (en) 1999-11-22 2001-05-31 The Research Foundation Of State University Of New York Magnetic nanoparticles for selective therapy
AU3679801A (en) * 2000-02-08 2001-08-20 Rice University Optically-active nanoparticles for use in therapeutic and diagnostic methods
AU2002259107B2 (en) 2001-04-30 2006-10-26 Cytimmune Sciences, Inc. Colloidal metal compositions and methods
DE10154016B4 (de) 2001-10-26 2004-02-12 Berlin Heart Ag Magnetflüssigkeit und Verfahren zur ihrer Herstellung
WO2003075961A2 (en) * 2002-03-08 2003-09-18 James Hainfeld Gold nanoparticles used for x-rays imaging
US7769423B2 (en) 2002-09-11 2010-08-03 Duke University MRI imageable liposomes for the evaluation of treatment efficacy, thermal distribution, and demonstration of dose painting
US20030125283A1 (en) 2002-09-16 2003-07-03 Gatenby Robert A. Therapy of proliferative disorders by direct irradiation of cell nuclei with tritiated nuclear targetting agents
US7235228B2 (en) 2003-04-15 2007-06-26 The United States Of America As Represented By The Secretary Of The Navy Fluorescent-magnetic nanoparticles with core-shell structure
US20050084869A1 (en) 2003-10-20 2005-04-21 Sung Hyun Kim Novel composition and methods for the diagnosis of lung cancer
WO2005046733A1 (en) 2003-11-17 2005-05-26 Philips Intellectual Property & Standards Gmbh Contrast agent for medical imaging techniques and usage thereof
CA2547024C (en) 2003-12-22 2013-12-17 Bracco Research Sa Gas-filled microvesicle assembly for contrast imaging
JP4895151B2 (ja) * 2004-02-27 2012-03-14 日立金属株式会社 鉄系ナノサイズ粒子およびその製造方法
FR2869803B1 (fr) 2004-05-10 2006-07-28 Nanobiotix Sarl Particules activables, preparation et utilisations
US20050260137A1 (en) 2004-05-18 2005-11-24 General Electric Company Contrast agents for magnetic resonance imaging
US20070031337A1 (en) 2004-06-22 2007-02-08 Reinhard Schulte Nanoparticle enhanced proton computed tomography and proton therapy
GB2415374A (en) 2004-06-25 2005-12-28 Leuven K U Res & Dev Targeted delivery of biologically active substances using iron oxide/gold core-shell nanoparticles
WO2006037081A2 (en) * 2004-09-28 2006-04-06 The Regents Of The University Of California Nanoparticle radiosensitizers
WO2006051732A1 (ja) 2004-11-10 2006-05-18 Konica Minolta Medical & Graphic, Inc. 被覆磁性粒子含有製剤およびその製造方法、並びに診断治療システム
US20070092927A1 (en) 2005-06-13 2007-04-26 University Of Dayton Photocatalytic particles with directed and controlled redox activity
US20090304587A1 (en) 2005-11-01 2009-12-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Biodegradable composite for internal local radiotherapy
US20070098640A1 (en) * 2005-11-02 2007-05-03 General Electric Company Nanoparticle-based imaging agents for X-ray/computed tomography
KR100745744B1 (ko) * 2005-11-11 2007-08-02 삼성전기주식회사 나노 입자 코팅 방법
WO2007122956A1 (ja) 2006-03-24 2007-11-01 Toto Ltd. 酸化チタン複合体粒子、その分散液、およびそれらの製造方法
JP2009536151A (ja) 2006-03-30 2009-10-08 富士フイルム株式会社 ナノ粒子
EP1852107A1 (en) 2006-04-19 2007-11-07 Nanobiotix Magnetic nanoparticles compositions and uses thereof
US20090191128A1 (en) 2006-07-10 2009-07-30 Koninklijke Philips Electronics N.V. Core-shell nanoparticles for thearapy and imaging purposes
DE102006041495A1 (de) 2006-08-29 2008-03-20 Friedrich-Schiller-Universität Jena Substanzgemisch zur lokalen Deposition von Magnetpartikeln in einem Medium, insbesondere in tumorbefallenem organischem Gewebe, sowie Applikationskit zur Verabreichung
NO329127B1 (no) 2006-09-12 2010-08-30 Epitarget As Sporbart partikulaert materiale for legemiddelavlevering omfattende et matriseeller membranmateriale, et legemiddel, og et T1- og et T2*- magnetisk resonanskontrastmiddel
NO20064315L (no) 2006-09-22 2008-03-24 Epitarget As T1 MRI-sporbare medikamentavleveringspartikler and anvendelse derav
EP1920784A1 (en) 2006-11-13 2008-05-14 Koninklijke Philips Electronics N.V. Radiation sensitizers in ionizing radiation therapy and imaging
US20090004258A1 (en) 2007-06-27 2009-01-01 National Health Research Institutes Drug Release from Thermosensitive Liposomes by Applying an Alternative Magnetic Field
JP2009067613A (ja) * 2007-09-11 2009-04-02 Fujifilm Corp コア−シェル型金属酸化物微粒子及びその製造方法
US20120176016A1 (en) * 2007-09-28 2012-07-12 General Electric Company Core-shell particulates, articles, and method of making
FR2922106B1 (fr) 2007-10-16 2011-07-01 Univ Claude Bernard Lyon Utilisation de nanoparticules a base de lanthanides comme agents radiosensibilisants.
EP2067485A1 (en) 2007-12-07 2009-06-10 Koninklijke Philips Electronics N.V. Drug carrier providing MRI contrast enhancement
WO2009081287A2 (en) 2007-12-21 2009-07-02 University Of Guelph Polysaccharide nanoparticles
WO2009091597A2 (en) 2008-01-16 2009-07-23 Nanospectra Biosciences, Inc. Treatments of disease or disorders using nanoparticles for focused hyperthermia to increase therapy efficacy
DE102008008522A1 (de) 2008-02-11 2009-08-13 Magforce Nanotechnologies Ag Implantierbare Nanopartikel-enthaltende Produkte
WO2009142754A1 (en) 2008-05-22 2009-11-26 Goverment Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Dendritic conjugates and methods of use
EP2130553A1 (en) 2008-06-05 2009-12-09 Nanobiotix Inorganic nanoparticles of high density to destroy cells in-vivo
GB0811300D0 (en) * 2008-06-19 2008-07-30 Syngenta Participations Ag Methods of controlling neonicotinoid resistant insects
WO2010048623A2 (en) 2008-10-26 2010-04-29 Board Of Regents, The University Of Texas Systems Medical and imaging nanoclusters
EP2275137A1 (en) 2009-07-10 2011-01-19 Nanobiotix Metallic nanoparticles, preparation and uses thereof
EP2305310A1 (en) 2009-09-25 2011-04-06 Asociación Centro de Investigación Cooperativa en Biomateriales - CIC biomaGUNE Gold -coated magnetic glyconanoparticles functionalised with proteins for use as diagnostic and therapeutic agents
GB0921596D0 (en) 2009-12-09 2010-01-27 Isis Innovation Particles for the treatment of cancer in combination with radiotherapy
US8580312B2 (en) 2010-02-17 2013-11-12 National University Corporation Kobe University Radiation therapy agent
WO2011127061A1 (en) 2010-04-05 2011-10-13 Nanospectra Biosciences, Inc. Enhancement of radiation therapy by targeted high-z nanoparticles
GB201009455D0 (en) 2010-06-04 2010-07-21 King S College London Nanoparticles and their uses in molecular imaging
WO2012104275A2 (en) 2011-01-31 2012-08-09 Nanobiotix Nanoparticles delivery systems, preparation and uses thereof
EP2670393B8 (en) 2011-01-31 2016-10-05 Nanobiotix Method of monitoring the release from liposomes of a product of interest using superparamagnetic nanoparticles.
EA029635B1 (ru) 2011-12-16 2018-04-30 Нанобиотикс Применение наночастицы, включающей металлический материал, покрытый материалом оксида гафния, в онкологии и композиция, ее содержащая
AR094577A1 (es) 2013-01-25 2015-08-12 Nanobiotix Composiciones para el tratamiento de cáncer, preparación y usos de las mismas
WO2014121224A2 (en) 2013-02-01 2014-08-07 The Trustees Of Dartmouth College Biodegradable iron oxide nanoparticle gel for tumor bed therapy
WO2014191569A1 (en) 2013-05-30 2014-12-04 Nanobiotix Pharmaceutical composition, preparation and uses thereof
US20160136304A1 (en) 2013-06-20 2016-05-19 Nanobiotix Compositions and methods for use in oncology
EA201690050A1 (ru) 2013-06-20 2016-05-31 Нанобиотикс Композиции и способы для применения в медицинской диагностике
EP2886128A1 (en) 2013-12-20 2015-06-24 Nanobiotix Pharmaceutical composition comprising nanoparticles, preparation and uses thereof

Similar Documents

Publication Publication Date Title
JP2015509079A5 (https=)
Altinbasak et al. Reduced graphene-oxide-embedded polymeric nanofiber mats: an “on-demand” photothermally triggered antibiotic release platform
JP2012532120A5 (https=)
EP2481402A3 (en) Nanoparticle comprising rapamycin and albumin as anticancer agent
HRP20202005T1 (hr) Metalne nanočestice, njihova priprava i uporaba
JP2012530780A5 (https=)
CN109843301B (zh) 用于递送治疗剂的含金属硅酸盐的多孔硅材料
JP2014505736A5 (https=)
JP2014514022A5 (https=)
JP2019503325A5 (https=)
WO2009139939A3 (en) Hybrid nanoparticles as anti-cancer therapeutic agents and dual therapeutic/imaging contrast agents
EP2201077A4 (en) ULTRAHOLE-MOLECULAR POLYMER COMPLEXES TARGETED WITH ADJUSTABLE NITROGEN MONOXIDE FOR WOUND HEALING
JP2016504368A5 (https=)
JP2014534342A5 (https=)
JP2011521654A5 (https=)
JP2010510260A5 (https=)
WO2008022146A3 (en) Polymer-surfactant nanoparticles for sustained release of compounds
JP2011527697A5 (https=)
HK1203353A1 (en) Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof
JP2017508724A5 (https=)
JP2013509394A5 (https=)
JP2017514800A5 (https=)
JP2011173866A5 (https=)
JP2009532434A5 (https=)
Farooq et al. Ag and MoO3 nanoparticle-containing polyacrylonitrile nanofiber membranes for wound dressings